Research funder · United States
American Cancer Society
Health organization seeking to cure and treat cancer
- Grants since 2016
- 2 163
- Awarded, last 5 years (where amounts are published)
- 648.5M
- Funded works, last 5 years
- 5 405
- Funded works, all time
- 33.1k
Grants
2025–2027 · award
INVESTIGATING SAFETY-NET FINANCIAL ACCOUNT DATA FOR CANCER HEALTH SERVICES RESEARCH
Arthur Hong · The University Of Texas Southwestern Medical Center (ut Southwestern)
2025–2029 · award
Targeting the IWS1/ENAH axis to prevent invasion and metastases of liposarcoma
Joal Beane · The Ohio State University
2025–2028 · award
Adjuvanting Polypeptides for Developing Potent mRNA Vaccines against Solid Tumors
Hua Wang · University of Illinois Urbana-Champaign
2025–2028 · award
Targeting Glycogen Metabolism in PI3K/AKT pathway-driven cancers
Tashbib Khan · Beth Israel Deaconess Medical Center
2025–2026 · award
Role of Sialic acid-Siglec axis in pancreatic cancer immune evasion
Barnita Haldar · University of Alabama at Birmingham
2025–2027 · award
Investigating a novel role of NAD+-derived metabolite in tumor fat metabolism
Songhua Hu · Harvard University
2025–2030 · award
William R. Sellers ACS Professorship Application
William Sellers · Broad Institute
2025–2026 · award
Developing nanodisc-ID to profile cell surface interactome for cancer-specific antigen and antibody Discovery
Huan Bao · University of Virginia
2025–2026 · award
Identification of Small Molecule Inhibitors of Nuclear Pore Formation for Cancer Therapies
Maximiliano Dangelo · Sanford Burnham Prebys Medical Discovery Institute
2025–2027 · award
Institutional Research Grant
Daniel Dimaio · Yale University
2025–2027 · award
Identification of endoplasmic reticulum associated degradation inhibitors for treatment of multiple myeloma
Qing Li · Regent University
2025–2028 · award
AIRE deficiency as a strategy for stress-induced apoptosis and regression of pre-cancerous skin lesionshere, then press Save.
Ryan Hobbs · Pennsylvania State University
2025–2026 · award
Assessing the Therapeutic Potential of PARPi and PROTACs in BRCA-Mutated Cancers
Sehbanul Islam · University of Pennsylvania
2025–2026 · award
The therapeutic potential of targeting endosomal trafficking and recycling in chemoresistant ovarian cancer
Yang Yang-Hartwich · Yale University
2025–2028 · award
KLF4 drives resistance to chemotherapy through a hillock-like state in lung squamous cell carcinoma
Luke Izzo · Duke University
2025–2028 · award
Deciphering the structural basis of HER receptor signaling across the cell membrane
Allison Maker · Regent University
2025–2028 · award
Oklahoma Cancer Health Equity Research Center
Darla Kendzor · Board Of Regents Of The University Of Oklahoma, Health Sciences Center
2025–2028 · award
Red hair and Rho: exploring the intersection of genetic predisposition and carcinogenic signaling during melanoma initiation
Robert Judson-Torres · University of Utah
2025–2027 · award
Cultivating Undergraduate Research Excellence in Cancer (CURE-Cancer)
Edward Nelson
2025–2026 · award
Synthetic lethality with BET bromodomain inhibition
Scott Floyd · Duke University
2025–2030 · award
Improving the Delivery of Cancer Care
Dawn Hershman · The Trustees Of Columbia University In The City Of New York
2025–2028 · award
Interplay of mechanical cues and metabolisms by MAP4K-Hippo signaling in hepatocarcinogenesis
Zhipeng Meng · University of Miami
2025–2027 · award
Combining irreversible electroporation with trained immunity to enhance anti-PD-1 therapy in patients with locally advanced pancreatic cancer
Jun Yan · University Of Louisville Research Foundation, Inc.
2025 · award
Multi-layer data integration to inform activity-based diagnostics for colorectal cancer classification
Liangliang Hao · Trustees Of Boston University
2025–2026 · award
A novel animal model for discovery of pathways/genes involved in Helicobacter-associated gastric cancer progression.
Marygorret Obonyo · Regent University
2025–2029 · award
Targeted Approach to Upper Gastrointestinal Cancer Screening
Ji Yoon Yoon · Mount Sinai Hospital
2025 · award
Evaluation of combination therapies to block off-target activation of GCN2 by BRAF and other kinase inhibitors
Sabrina Spencer · University of Colorado Boulder
2025–2027 · award
Generating a B-progenitor acute lymphoblastic leukemia cell library to study chimeric antigen receptor T cell-induced lineage switch
Zachary Rogers · Massachusetts Institute of Technology
2025–2027 · award
Delineating Multi-Organ Metastasis in Triple Negative Breast Cancer with Single Cell Genomics
Rachel Dittmar · The University of Texas MD Anderson Cancer Center
2025–2027 · award
Targeting PD-1 glycosylation to enhance multilineage immune checkpoint blockade
Christina Martins · Brigham and Women's Hospital
2025–2029 · award
Immunosenescence and Cardiovascular Complications of Chemotherapy
Beshay Zordoky · Twin Cities Orthopedics
2025–2027 · award
Determining the influence of stromal cells on basal cell carcinoma growth
Anna Jussila · Stanford Medicine
2025–2027 · award
Targeting Lineage Plasticity of RB1/TP53 Mutant Lung Cancer
Yixiang Li · Dana-Farber Cancer Institute
2025–2028 · award
Geospatial Assessment of the Role of Exposome in Early Age at Onset Adult Cancers
Shannon Lynch · Fox Chase Cancer Center
2025–2028 · award
Metabolic adaptation at the interface of tumor-associated macrophage function, carcinoma growth, and treatment resistance
Justin Perry · Memorial Sloan Kettering Cancer Center
2025–2026 · award
Targeting ACSS2 for improving multiple myeloma therapy
Jing Yang · Methodist Hospital
2025–2028 · award
Exploring the hematopoietic niche to control hematopoietic stem cell egress using nanotechnology.
Gabriela Arias Alpizar · Boston Children's Hospital
2025–2026 · award
Mutant U2AF1 induced dysregulation of splicing and translation in myelodysplastic syndromes
Michael Alberti · University Of Colorado Denver, Amc And Dc
2025–2027 · award
Transforming Quality Metrics to Improve Tobacco Treatment in Medicaid
Nathalia Machado · University of Kansas Medical Center
2025–2026 · award
Integrating free-living data into digital twin models of glioblastoma
Rowan Barker-Clarke · Cleveland Clinic